Information Provided By:
Fly News Breaks for November 12, 2019
Nov 12, 2019 | 07:47 EDT
Raymond James analyst Jayson Bedford raised his price target for ICU Medical to $203 from $185, saying Q3 results were modestly ahead of expectations and presented a picture of stability compared to Q2. Bedford notes that there were some greenshoots in Q3, including positive updates on IV Sol'ns, U.S. infusion pumps and Consumables, and says the recent Pursuit deal adds a new growth driver. The analyst reiterates an Outperform rating.
News For ICUI From the Last 2 Days
There are no results for your query ICUI